Abstract: The present invention corresponds to the field of cancer and is related to predicting cancer detection, diagnosis, monitoring and prediction of response to treatment, in particular platelet derived-endothelial cell growth factor (PD-ECGF) levels for their use as a potential value in monitoring disease evolution and predicting response to anti-angiogenic treatment.

Abstract: The present invention corresponds to the field of cancer and is related to predicting cancer detection, diagnosis, monitoring and prediction of response to treatment, in particular platelet derived-endothelial cell growth factor (PD-ECGF) levels for their use as a potential value in monitoring disease evolution and predicting response to anti-angiogenic treatment.

Abstract: An automatic device for emptying bags of frozen blood product includes a product removal device, a product reception hopper, a transporter for transporting the bag from a reception area to the product removal device, and at least one cutter located in the path of the bag between the reception area and the product removal device. The at least one cutter is housed in a support configured to oscillate for absorbing energy of impacts of the bag against the cutter and to return the cutter to its initial position.

Abstract: An automatic device for emptying bags of frozen blood product includes a product removal device, a product reception hopper, a transporter for transporting the bag from a reception area to the product removal device, and at least one cutter located in the path of the bag between the reception area and the product removal device. The at least one cutter is housed in a support configured to oscillate for absorbing energy of impacts of the bag against the cutter and to return the cutter to its initial position.

Abstract: A method corrects the position and deviation of a syringe needle in a machine for automatically preparing intravenous medication. The machine includes an automatic actuator, together with a control system, in which are placed the syringe and a one-dimensional position sensor including a measuring plane. The correction method includes steps in which the position sensor obtains position coordinates of a first and a second point of the needle, and steps of correcting the position and deviation error of the needle, by the control system of the automatic actuator.

Abstract: The present invention corresponds to the field of cancer and is related to predicting cancer detection, diagnosis, monitoring and prediction of response to treatment, in particular platelet derived-endothelial cell growth factor (PD-ECGF) levels for their use as a potential value in monitoring disease evolution and predicting response to anti-angiogenic treatment.

Abstract: A method corrects the position and deviation of a syringe needle in a machine for automatically preparing intravenous medication. The machine includes an automatic actuator, together with a control system, in which are placed the syringe and a one-dimensional position sensor including a measuring plane. The correction method includes steps in which the position sensor obtains position coordinates of a first and a second point of the needle, and steps of correcting the position and deviation error of the needle, by the control system of the automatic actuator.

Abstract: This invention provides methods employing prefoldin-4 (PFDN-4) nucleic acid and polypeptide sequences to detect cancer or a propensity to develop cancer, to monitor the efficacy of a cancer treatment, and/or for prognostic applications. Further, the invention provides methods of identifying inhibitors of PfDN-4 and methods of treating cancer by inhibiting the expression and/or activity of PFDN-4.

Abstract: This invention provides methods employing prefoldin-4 (PFDN-4) nucleic acid and polypeptide sequences to detect cancer or a propensity to develop cancer, to monitor the efficacy of a cancer treatment, and/or for prognostic applications. Further, the invention provides methods of identifying inhibitors of PfDN-4 and methods of treating cancer by inhibiting the expression and/or activity of PFDN-4.